Neurotechnology company SyncThink has partnered with the Children’s National Medical Center in Washington, D.C. to examine ocular motor deficits in youths diagnosed with a concussion. The year-long investigation will study patients aged six to 16.
SyncThink’s flagship eye-tracking product, Eye-Sync, will be used to better understand vision and brain-function issues seen in children and adolescents after sustaining a concussion. Leading the study are physicians and researchers Gerard Gioia, director of the the Children’s National Safe Concussion Outcome Recovery and Education (SCORE) program, and Christopher Vaughan, the assistant director of SCORE.
“The SCORE program at Children’s National was established in 2003 with the mission of promoting developmentally appropriate assessment and treatment for children with concussion,” Dr.